top of page

Aquavit Pharmaceuticals Implements First-of-Kind Accelerate-to-Market Strategy

NEW YORK, September 2, 2011

Sobin Chang, CEO joined MBA students and faculty members at HAAS Business School, University of California at Berkley on September 1st, 2011 on the topic of “Innovation”. She explored the concept of shared value – developing linkages between business strategies and product development – and how it can unleash the next wave of global growth and redefine capitalism within an organization. The event was followed by Q&As and luncheon.

As CEO of Aquavit Pharmaceuticals, Chang is implementing an accelerated to-market strategy for their first line of proprietary products. Working with specialists across the board to implement niche foresight, R&D and commercialization strategy are being compressed in parallel with FDA regulatory pathways.

Recent Posts

See All


Post: Blog2_Post
bottom of page